LIXT News and Press, Lixte Biotechnology Holdings Inc. From 09/10/25

2025-09-10 12:59:40 ET DENVER, Colo., Sep 10, 2025 ( 247marketnews.com )- Lixte Biotechnology (NASDAQ:LIXT) is attracting investor attention as bullish sentiment builds around its lead compound LB‑100, a first-in-class Protein Phosphatase 2A (PP2A) inhibitor dubbed a “...

2025-09-09 14:47:34 ET DENVER, Colo., Sep 09, 2025 ( 247marketnews.com )- As markets push into the final hour of trading, all eyes are on a high-energy mix of biotech, AI, and consumer health stocks. Here are today’s standout plays going into the close. Lixte Biotechnology ...

2025-09-09 10:17:12 ET DENVER, Colo., Sep 09, 2025 ( 247marketnews.com )- Markets opened with strategic appointments and biotech breakthroughs. Here’s what’s catching investor attention: Donald Trump Jr. steps into the Octagon, as Strategic Advisor, for MMA.INC (...

2025-09-08 14:53:11 ET DENVER, Colo., Sep 08, 2025 ( 247marketnews.com )- As markets head into the final stretch of today’s session, all eyes are on a select group of stocks delivering outsized moves on game-changing clinical trial updates and growing institutional interest. Thes...

2025-09-08 10:21:24 ET DENVER, Colo., Sep 08, 2025 ( 247marketnews.com )- It’s a high-energy morning across markets as Wall Street opens with a surge of interest in clinical breakthroughs, speculative tech, and token-driven treasury strategies. Rapport Therapeutics (NASDAQ:...

2025-09-05 13:16:03 ET DENVER, Colo., Sep 05, 2025 ( 247marketnews.com )- As we push into the final stretch of today’s session, the late-day action is being driven by a tight pack of clinical-stage biotech disruptors, allergy care innovators, and digital real estate survivors. ...

2025-09-05 09:27:48 ET DENVER, Colo., Sep 05, 2025 ( 247marketnews.com )- LIXTE (NASDAQ:LIXT) headlines the morning buzz as it continues to position its lead compound, LB-100 , as a transformational player in oncology. LB-100 is the world’s only clinical-stage inhibitor...

2025-09-05 08:36:33 ET Unlocking a New Era in Cancer Treatment DENVER, Colo., Sep 05, 2025 ( 247marketnews.com )- LIXTE Biotechnology’s (NASDAQ:LIXT), a clinical-stage biotechnology company developing first-in-class inhibitors targeting protein phosphatases to enhance can...

Unlocking a New Era in Cancer Treatment Denver, Colorado--(Newsfile Corp. - September 5, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, underscores the scientific significance of LIXTE Biotechnology Ho...

2025-09-04 09:21:20 ET DENVER, Colo., Sep 04, 2025 ( 247marketnews.com )- As Wall Street gears up for today’s session, investors are keeping close tabs on biotech updates, dividend news, and a handful of small-cap disruptors making bold strategic plays. Here’s what you nee...